about
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceu...
Read More
9.83
-0.09
(-0.91%)
454.2K
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks have medium quality and momentum.Their expensive valuations suggest caution
View Similar
Embed DVM
Immatics N.V Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..